NAD therapy involves supplementing the body with nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in cellular energy production, to potentially ease withdrawal symptoms and support brain function during early addiction recovery. It's used as a complementary therapy in some detox and treatment settings. It's important to know upfront: NAD therapy is not FDA-approved for addiction treatment, and the supporting research consists mainly of small, uncontrolled studies rather than the kind of large randomized trials that establish a treatment as standard care. This guide covers what NAD+ actually does in the body, what the research supports and doesn't, and what to weigh before considering it.
NAD+ is a coenzyme every cell in the body produces naturally. It helps mitochondria convert nutrients into ATP, the molecule cells use for energy, and plays a role in DNA repair, metabolism, and cell signaling. NAD+ levels decline with age and under sustained physical stress, which has led some clinicians to explore whether restoring them can support recovery from conditions that place heavy demands on the body, including substance use disorders.
NAD therapy delivers NAD+ directly, most commonly through IV infusion, though intramuscular injection and nasal spray formulations exist as less common alternatives. Because the body already produces NAD+ naturally, it's generally well tolerated.
The evidence behind NAD therapy for addiction is real but limited. A literature review published via the National Library of Medicine notes that NAD+ metabolism appears to influence brain signaling pathways connected to addiction and craving, and that raising intracellular NAD+ levels is a plausible target worth studying further, while also noting that controlled clinical studies remain scarce. Most of the specific outcome data on IV NAD+ for withdrawal comes from small retrospective case series and pilot studies, including work published by NAD Research Inc., an organization with a direct commercial interest in the treatment protocol it studies, which is worth knowing when weighing how much confidence to place in those specific results. Those studies have reported reduced self-reported cravings and improved withdrawal comfort during opioid and alcohol detox, but they generally involve small samples, lack a placebo control group, and haven't been replicated in larger independent trials.
In short: there's a real biological rationale and some promising early signals, but not yet the level of evidence that would make NAD therapy a standard, guideline-recommended part of addiction treatment. Reputable clinics that offer it tend to frame it the same way, as a complementary option alongside evidence-based care, not a replacement for it.
IV infusions typically last 2 to 5 hours, during which patients can rest, read, or work. Clinics commonly recommend hydrating beforehand, eating a light meal, and avoiding caffeine or alcohol before a session. Reported side effects are generally mild: tenderness at the IV site, headache, temporary nausea if the infusion runs too quickly, or fatigue afterward. Protocols vary, but addiction-focused programs commonly administer NAD+ one to three times per week over four to ten weeks, often more frequently during the initial days of detox before tapering.
NAD+ is also marketed for DNA repair, anti-aging, and chronic conditions like fibromyalgia and chronic fatigue syndrome. NAD+'s general biological role in DNA repair and cellular metabolism is well established in basic science, but that's a different claim from showing that IV NAD+ infusions produce measurable anti-aging or disease-reversing effects in people, which has much thinner clinical support. It's worth treating those broader wellness claims with more skepticism than the addiction-specific withdrawal research, which, while still limited, at least has some pilot clinical data behind it.
NAD therapy is not a substitute for evidence-based addiction treatment such as therapy, medication-assisted treatment, or structured rehab programs, which have decades of controlled research behind them. Where it may add value is as a complementary comfort measure during medical detox, alongside, not instead of, established care. Some patients report less anxiety, improved sleep, and reduced brain fog during the withdrawal period when NAD+ is used this way, though individual results vary considerably and aren't guaranteed.
NAD therapy typically runs $350 to $600 per session, with a full multi-week protocol commonly costing $5,000 to $15,000 or more. Most insurance plans don't cover it, since it's classified as complementary or alternative care rather than a standard treatment. That cost is worth weighing carefully against the current strength of the evidence, particularly since the same budget could fund additional weeks of evidence-based residential or outpatient care.
NAD therapy may be reasonable to explore as a complementary comfort measure for someone going through detox, particularly if cost isn't a barrier and it's offered alongside, not in place of, medically supervised, evidence-based treatment. It's a weaker fit for anyone expecting it to meaningfully change addiction outcomes on its own, or anyone drawn in primarily by the anti-aging or chronic-disease claims, where the evidence is thinner still. The strongest approach remains comprehensive treatment addressing the psychological, behavioral, and medical dimensions of addiction, with NAD+ treated as an optional add-on rather than a core pillar of the plan.
Frequently asked questions
No. NAD therapy is not FDA-approved for treating substance use disorders. It's offered by some clinics as a complementary therapy, but it sits outside standard, guideline-recommended addiction treatment.
Limited. Most supporting data comes from small retrospective case series and pilot studies without placebo controls, some published by organizations with a commercial interest in the treatment. There's a plausible biological rationale, but not yet large independent clinical trials confirming effectiveness.
No. It's considered a complementary option at most, not a substitute for evidence-based treatments like therapy, medication-assisted treatment, or structured rehab programs, which have a much larger body of research behind them.
Individual sessions generally run $350 to $600, with full multi-week protocols costing $5,000 to $15,000 or more. Most insurance plans don't cover it since it's classified as complementary care.
Reported side effects are generally mild: tenderness at the IV site, headache, temporary nausea if the infusion is administered too quickly, or fatigue afterward. Clinics typically slow the infusion rate if discomfort occurs.
Those claims should be treated with more caution than the addiction-specific research. NAD+'s general role in cellular metabolism and DNA repair is well established in basic science, but that's different from clinical evidence that IV infusions meaningfully reverse aging or resolve chronic conditions in people, where the data is considerably thinner.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
